Decoy Therapeutics Inc. (DCOY)
Last updated: 2026-10-24 20:12:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Decoy Therapeutics Inc. (DCOY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.99, with a market capitalization of $674.84K and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.96 to $16.92. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$674.84K | |
$0.99 | |
$16.92 | |
$0.96 | |
$1.03 | |
342.00 | |
2.19M | |
-- | |
$16.92 | |
$0.96 | |
-- | |
-- |
Decoy Therapeutics Inc. (DCOY) Latest Closing Stock Price
Decoy Therapeutics Inc. (DCOY) last closed at $1.03 as of 2026-10-23 23:44:00, unchanged from the previous close of $1.03.
During the latest regular trading session, DCOY traded between $0.96 and $16.92, with a volume of 342.00 shares. The closing price was near the lower end and near the lower end of its 52-week range.
Decoy Therapeutics Inc. (DCOY) 7-Day Stock Price Change
Over the past seven days, Decoy Therapeutics Inc. (DCOY) moved from $1.23 to $0.99, representing a decline of 19.92% ($0.25).
The stock traded between $0.96 and $1.28 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 52.14 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
DCOY 52-Week Price Position
Position in Range: 0.2%
DCOY is currently trading at $0.99, placing it 0.2% of the way from its 52-week low of $0.96 to its 52-week high of $16.92. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Decoy Therapeutics Inc. (DCOY)?
Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.
Decoy Therapeutics Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 11 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Decoy Therapeutics Inc. (DCOY) Stock on MEXC
Eligible investors can buy real shares of Decoy Therapeutics Inc. (DCOY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Decoy Therapeutics Inc. (DCOY) stock price today?
2.Is DCOY stock going up or down today?
3.What is DCOY pre-market price?
4.What is DCOY after-hours price?
5.Is DCOY stock trading now?
6.Where does DCOY sit relative to its 52-week high and low?
7.What sector is Decoy Therapeutics Inc. in?
8.What is Decoy Therapeutics Inc.'s market capitalization and where is it listed?
9.How is DCOY valued in terms of P/E ratio and EPS?
10.Does Decoy Therapeutics Inc. pay a dividend?
Explore More US Stocks
Search Stocks
DCOY Stock Calculator
Estimate the value between DCOY shares and USD.
DCOY Shares to USD
1.00 DCOY shares = 0.985 USD
Calculations are estimates based on the latest available price and are for reference only.


